NCT04881045 Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors. Status COMPLETED Phase PHASE1
NCT04880447 Special Investigation of COMIRNATY in the Population With Underlying Diseases Status COMPLETED Phase N/A
NCT04878731 Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia Status COMPLETED Phase PHASE1
NCT04875533 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan Status COMPLETED Phase PHASE3
NCT04873895 TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC) Status TERMINATED Phase PHASE1
NCT04871789 Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19 Status UNKNOWN Phase N/A
NCT04866225 A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571. Status COMPLETED Phase PHASE1
NCT04863417 Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy Participants Status COMPLETED Phase PHASE1
NCT04858997 Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese Patients Status UNKNOWN Phase PHASE2
NCT04856293 Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS) Status COMPLETED Phase PHASE1
NCT04849364 Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT04848584 Pfizer-BioNTech COVID-19 Vaccine Effectiveness Study - Kaiser Permanente Southern California Status COMPLETED Phase N/A
NCT04848220 A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention Status TERMINATED Phase PHASE2
NCT04846478 Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04842604 Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML Status COMPLETED Phase PHASE3
NCT04841148 Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer Status RECRUITING Phase PHASE2
NCT04839393 A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy Status COMPLETED Phase PHASE1